Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy
Introduction: Paraneoplastic autoantibody screening of 150,000 patient sera by tissue‐based immunofluorescence incidentally revealed 170 with unsuspected signal recognition particle (SRP) immunoglobulin G (IgG), which is a recognized biomarker of autoimmune myopathy. Of the 77 patients with availab...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067628/ |
id |
pubmed-5067628 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-50676282016-11-01 Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy Apiwattanakul, Metha Milone, Margherita Pittock, Sean J. Kryzer, Thomas J. Fryer, James P. O'toole, Orna Mckeon, Andrew Lennon, Vanda A. Clinical Research Introduction: Paraneoplastic autoantibody screening of 150,000 patient sera by tissue‐based immunofluorescence incidentally revealed 170 with unsuspected signal recognition particle (SRP) immunoglobulin G (IgG), which is a recognized biomarker of autoimmune myopathy. Of the 77 patients with available information, 54 had myopathy. We describe the clinical/laboratory associations. Methods: Distinctive cytoplasm‐binding IgG (mouse tissue substrate) prompted western blot, enzyme‐linked immunoassay, and immunoprecipitation analyses. Available histories were reviewed. Results: The immunostaining pattern resembled rough endoplasmic reticulum, and mimicked Purkinje‐cell cytoplasmic antibody type 1 IgG/anti‐Yo. Immunoblotting revealed ribonucleoprotein reactivity. Recombinant antigens confirmed the following: SRP54 IgG specificity alone (17); SRP72 IgG specificity alone (3); both (32); or neither (2). Coexisting neural autoantibodies were identified in 28% (low titer). Electromyography revealed myopathy with fibrillation potentials; 78% of biopsies had active necrotizing myopathy with minimal inflammation, and 17% had inflammatory myopathy. Immunotherapy responsiveness was typically slow and incomplete, and relapses were frequent on withdrawal. Histologically confirmed cancers (17%) were primarily breast and hematologic, with some others. Conclusions: Autoimmune necrotizing SRP myopathy, both idiopathic and paraneoplastic, is underdiagnosed in neurological practice. Serological screening aids early diagnosis. Cancer surveillance and appropriate immunosuppressant therapy may improve outcome. Muscle Nerve 53: 925–932, 2016 John Wiley and Sons Inc. 2016-02-05 2016-06 /pmc/articles/PMC5067628/ /pubmed/26561982 http://dx.doi.org/10.1002/mus.24970 Text en © 2015 The Authors. Muscle & Nerve Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Apiwattanakul, Metha Milone, Margherita Pittock, Sean J. Kryzer, Thomas J. Fryer, James P. O'toole, Orna Mckeon, Andrew Lennon, Vanda A. |
spellingShingle |
Apiwattanakul, Metha Milone, Margherita Pittock, Sean J. Kryzer, Thomas J. Fryer, James P. O'toole, Orna Mckeon, Andrew Lennon, Vanda A. Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy |
author_facet |
Apiwattanakul, Metha Milone, Margherita Pittock, Sean J. Kryzer, Thomas J. Fryer, James P. O'toole, Orna Mckeon, Andrew Lennon, Vanda A. |
author_sort |
Apiwattanakul, Metha |
title |
Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy |
title_short |
Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy |
title_full |
Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy |
title_fullStr |
Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy |
title_full_unstemmed |
Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy |
title_sort |
signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy |
description |
Introduction: Paraneoplastic autoantibody screening of 150,000 patient sera by tissue‐based immunofluorescence incidentally revealed 170 with unsuspected signal recognition particle (SRP) immunoglobulin G (IgG), which is a recognized biomarker of autoimmune myopathy. Of the 77 patients with available information, 54 had myopathy. We describe the clinical/laboratory associations. Methods: Distinctive cytoplasm‐binding IgG (mouse tissue substrate) prompted western blot, enzyme‐linked immunoassay, and immunoprecipitation analyses. Available histories were reviewed. Results: The immunostaining pattern resembled rough endoplasmic reticulum, and mimicked Purkinje‐cell cytoplasmic antibody type 1 IgG/anti‐Yo. Immunoblotting revealed ribonucleoprotein reactivity. Recombinant antigens confirmed the following: SRP54 IgG specificity alone (17); SRP72 IgG specificity alone (3); both (32); or neither (2). Coexisting neural autoantibodies were identified in 28% (low titer). Electromyography revealed myopathy with fibrillation potentials; 78% of biopsies had active necrotizing myopathy with minimal inflammation, and 17% had inflammatory myopathy. Immunotherapy responsiveness was typically slow and incomplete, and relapses were frequent on withdrawal. Histologically confirmed cancers (17%) were primarily breast and hematologic, with some others. Conclusions: Autoimmune necrotizing SRP myopathy, both idiopathic and paraneoplastic, is underdiagnosed in neurological practice. Serological screening aids early diagnosis. Cancer surveillance and appropriate immunosuppressant therapy may improve outcome. Muscle Nerve
53: 925–932, 2016 |
publisher |
John Wiley and Sons Inc. |
publishDate |
2016 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067628/ |
_version_ |
1613687232062816256 |